Advertisement
Screener

Bicycle Therapeutics plc (BCYC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Bicycle Therapeutics plc Cash Flow Breakdown

Cash flow breakdown shows where Bicycle Therapeutics plc's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $249.68M went out.
  • Fiscal year ended 2025-12-31: from investing, $2.35M went out.
  • Fiscal year ended 2025-12-31: from financing, $131.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $251.35M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$249.68M-$2.35M$37.00K-$251.35M
2024-12-31-$164.72M-$1.24M-$31.86M$544.13M$7.49M*$353.10M
2023-12-31-$60.63M-$2.93M$249.34M$682.00K*$187.82M
2022-12-31-$86.11M-$18.99M$5.70M$989.00K*-$99.53M
2021-12-31-$14.79M-$2.03M$15.00M$290.98M$14.74M*$302.69M
2020-12-31-$17.79M-$1.20M$15.00M$48.14M$43.87M
2019-12-31-$28.61M-$1.55M$143.00K$58.30M*$28.74M
2018-12-31-$26.08M-$1.19M$1.00K$25.43M*-$4.28M
2017-12-31-$1.42M-$1.11M$1.00K$57.88M*$58.26M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$49.61M*-$265.00K*$1.00K*
2026-03-31-$65.92M-$713.00K$12.00K-$68.64M
2025-12-31-$19.35M*-$574.00K*$33.00K*
2025-09-30-$71.17M*-$674.00K*$1.00K*
2025-06-30-$72.79M*-$498.00K*$1.00K*
2025-03-31-$86.37M-$604.00K$2.00K-$86.55M
2024-12-31-$9.40M*-$368.00K*$0.00*$0.00*
2024-09-30-$39.83M*-$435.00K*-$979.00K*-$30.95M*
2024-06-30-$44.63M*-$420.00K*$4.50M*$545.11M*
2024-03-31-$70.87M-$12.00K$1.87M-$69.43M
2023-12-31-$47.29M*-$51.00K*$10.00K*
2023-09-30-$1.02M*-$502.00K*$234.49M*
2023-06-30$34.10M*-$277.00K*$12.13M*
2023-03-31-$46.41M-$2.10M$2.72M-$45.34M
2022-12-31-$30.31M*-$1.45M*$185.00K*$5.70M*
2022-09-30-$5.87M*-$2.98M*$159.00K*
2022-06-30-$23.53M*-$9.80M*$195.00K*
2022-03-31-$26.40M-$4.76M$450.00K-$31.31M
2021-12-31-$10.44M*-$1.07M*$0.00*$188.39M*$2.27M*
2021-09-30$21.72M*-$169.00K*$0.00*$29.84M*$10.61M*
2021-06-30-$12.37M*-$171.00K*$0.00*$1.57M*$13.98M*
2021-03-31-$13.71M-$623.00K$15.00M$284.00K$58.77M*$59.91M
2020-12-31-$16.62M*-$484.00K*$0.00*$173.00K*$1.57M*
2020-09-30-$9.98M*-$95.00K*$87.00K*$61.00M*
2020-06-30-$12.35M*-$301.00K*$9.00K*
2020-03-31$21.16M-$320.00K$2.00K$17.52M
2019-12-31-$4.92M*-$391.00K*$122.00K*
2019-09-30-$10.88M*-$283.00K*$0.00*-$811.00K*
2019-06-30-$7.61M*-$463.00K*$59.09M*
2019-03-31-$5.20M-$418.00K-$4.02M
2018-12-31-$8.85M*-$410.00K*$25.43M*
2018-09-30-$4.66M*-$126.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
ProMIS Neurosciences Inc. (PMN)$0.102B